Johnson & Johnson (LIM:JNJ) Asset Impairment Charge : $250 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Asset Impairment Charge?

Johnson & Johnson's Asset Impairment Charge for the three months ended in Mar. 2025 was $30 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was $250 Mil.

Johnson & Johnson Asset Impairment Charge Historical Data

The historical data trend for Johnson & Johnson's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Asset Impairment Charge Chart

Johnson & Johnson Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

233.00

989.00

1,216.00

1,295.00

405.00

Johnson & Johnson Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															185.00	194.00	-	26.00	30.00

Johnson & Johnson Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $250 Mil.

Johnson & Johnson Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (LIM:JNJ) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria JNJ:Argentina

Address

One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.